
Supriya Pharmaceuticals Limited
About Supriya Pharmaceuticals Limited
Data last updated:
Supriya Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 July 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U01100DL1985PLC445217. Its GSTIN is 07AAFCS4958R2ZE (Delhi). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.64 Cr. It is led by directors including Manish Gupta and Ramesh Dugar.
Its last annual general meeting (AGM) was held on 04 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001.
As per MCA filings, the company has open charges of ₹3 Cr and satisfied charges of ₹7.94 Cr on record. Court records list 18 cases involving the company, including 6 filed by the company and 12 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Supriya Pharmaceuticals has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U01100DL1985PLC445217, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U01100DL1985PLC445217 | Current |
| U24232RJ1985PLC003363 | Previous |
| L24232RJ1985PLC003363 | Previous |
| U01100RJ1985PLC003363 | Previous |
Contact details
Supriya Pharmaceuticals Limited's registered office is in New Delhi, Delhi.
- Registered Address810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Supriya Pharmaceuticals Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Supriya Pharmaceuticals Limited, buy the company report.
Board of directors of Supriya Pharmaceuticals Limited
Supriya Pharmaceuticals has 3 current directors and 14 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Gupta | Nominee Director | 06 Feb 2024 | 2 Years 9 Months | Current |
| Ramesh Dugar Also directs: Dakesh Builders Pvt Ltd, Tarini Overseas Private Limited, R Net Intelligence Systems Private Limited and 3 more | Nominee Director | 08 Feb 2012 | 14 Years 9 Months | Current |
| Yogesh Kumar Also directs: Trancelogics Private Limited | Nominee Director | 16 May 2017 | 9 Years 6 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Aug 2005 | 90069297 | United Bank of India | ₹3 Cr | Satisfied | |
| 21 Jan 1998 | 90066760 | Canara Bank | ₹3 Lakh | Satisfied | |
| 20 Aug 1992 | 90067909 | Canara Bank | ₹3 Cr | Satisfied | |
| 31 Jan 1992 | 90066359 | Canara Bank | ₹30 Lakh | Satisfied | |
| 16 Aug 1991 | 90066351 | Canara Bank | ₹55 Lakh | Satisfied |
To see the full charge records of Supriya Pharmaceuticals Limited, buy the company report.
Total charge records: 9 View all charges
Legal cases
Supriya Pharmaceuticals Limited has 18 court cases on record: 6 filed by Supriya Pharmaceuticals, 12 filed against it. 2 cases are pending and 16 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 9 | 5 | 0 |
| District courts | 6 | 6 | 1 |
| Supreme Court | 2 | 1 | 1 |
| NCLAT | 1 | 0 | 0 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLAT, Chairperson Court | Tribunal matter | Filed by the company against M/S Samriddhi Mega Structures Limited and 5 others | Disposed |
| High Court of Delhi | Writ petition | Filed against the company by United Bank of India | Disposed |
| High Court, CHANDIGARH (UT) | Company petition | Filed by the company against M/S Ranbaxy Laboratories Limited | Disposed |
| High Court of Delhi | Writ petition | Filed by the company against United Bank of India | Disposed |
| District court, Vadodara, Gujarat | Criminal complaint | Filed against the company by M/S. Alembic Ltd. | Disposed |
To see the full case history of Supriya Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Supriya Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Supriya Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCS4958R2ZE | Delhi | Active | 27 Nov 2017 |
To see the full GST registrations and return filing status of Supriya Pharmaceuticals Limited, buy the company report.
Recent activity
Supriya Pharmaceuticals Limited has 17 board changes on record since 2007: 3 appointments and 14 cessations. The latest: Manish Gupta was appointed as Nominee Director on 06 Feb 2024.
28 earlier events are in the company report.
Frequently asked questions
Supriya Pharmaceuticals is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 July 1985 (41+ years old) and is registered under CIN U01100DL1985PLC445217.
Supriya Pharmaceuticals has 3 current directors:
- Manish Gupta - Nominee Director
- Ramesh Dugar - Nominee Director
- Yogesh Kumar - Nominee Director
The latest financial statements of Supriya Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 June 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Supriya Pharmaceuticals is 07AAFCS4958R2ZE, registered in Delhi. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Supriya Pharmaceuticals is U01100DL1985PLC445217. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Supriya Pharmaceuticals has 18 court cases on record: 6 filed by the company and 12 filed against it. 2 are pending. Most are in the high courts.
Supriya Pharmaceuticals was incorporated on 24 July 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Manish Gupta was appointed as Nominee Director on 06 Feb 2024. Rajeev Dugar ceased to be Director on 06 Feb 2024. Ramesh Dugar ceased to be Director on 05 Feb 2024. Supriya Pharmaceuticals has 17 board changes on record in total.
The registered office of Supriya Pharmaceuticals is at 810 Arunachal Building, 19 Barkhamba Road Connaught Place, New Delhi, Delhi, India – 110001.
Supriya Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

